 |
|
Researchers find 1 in 6 women, 1 in 10 men at risk for Alzheimer's disease in their lifetime
March 19, 2008Boston, MA-Researchers from Boston University School of Medicine (BUSM) have estimated that one in six women are at risk for developing Alzheimer's disease (AD) in their lifetime, while the risk for men is one in ten. These findings were released today by the Alzheimer's Association in their publication 2008 Alzheimer's Disease: Facts and Figures.
Stroke and dementia are the most widely feared age-related neurological diseases, and are also the only neurological disorders listed in the ten leading causes of disease burden.
"The realization that the lifetime risk of stroke or dementia was more than one in three in both sexes, which is higher than the lifetime risk of coronary heart disease in women, is sobering," said lead author Sudha Seshadri, MD, an associate professor of neurology at BUSM and an investigator of the Framingham Heart Study.
According to the researchers, the greater lifetime expectancy for women translates into a greater lifetime risk of several diseases.
"People should be aware of the risk of a disease at some point in their life. Similarly, such statistics are essential for public health planners to estimate the projected disease burden in a population during its expected lifespan," adds Seshadri.
Boston University
More Alzheimer’s Disease Current Events and Alzheimer’s Disease News Articles
 |
Pharmacogenomics in Drug Discovery and Development (Methods in Molecular Biology) by Qing Yan (Editor) Since each human is genetically distinctive, responding differently to disease-causing factors as well as drugs, the field pharmacogenomics arose to develop personalized medicine, or medicine that deals with the complexity of the human body. In Pharmacogenomics in Drug Discovery and Development, leading experts present methodical, state-of-the-art contributions covering topics from individual molecules to systemic diseases, examining both fundamental concepts and advanced technologies. Divided into three sections, the volume begins by exploring cutting-edge technologies used to pursue systems-based pharmacogenomics, followed by extensive chapters on gene-drug interactions and the use of pharmacogenomics in therapeutics of diseases. Comprehensive and up-to-date, Pharmacogenomics... |
 |
New Science of Alzheimer's Disease / TIME Cover: July 17, 2000, Framed Art Print by TIME Magazine by barewalls The most eagerly awaited event in the editorial cycle at TIME Magazine is always the selection of the cover. The best covers capture the zeitgeist of the week while surviving the judgment of history. As browsing this collection of TIME cover art prints shows, TIME is as good a record as any of who and what mattered over the past 80-plus years. And so when TIME captures a person, an event or a trend within its iconic red borders, the magazine is adding that extra dose of significance that no other publication can quite match. That is one reason why the original artwork for more than 800 TIME covers now resides in the National Portrait Gallery in Washington. Thanks to an amazing roster of artists, photographers and graphic designers, from TIME's earliest charcoal drawings of cover subjects... |
 |
The Forgetting - A Portrait of Alzheimer's Starring: David Hyde Pierce Directed By: Elizabeth Arledge Also With: Elizabeth Arledge (Producer), Doug Quade (Editor), Naomi S. Boak (Producer), Whitney Johnson (Producer) Studio: Paramount Home Video Release Date: 11/01/2005 |
|
Alzheimer’s Disease Chart by American 3B Scientific Alzheimer’s Disease Chart Alzheimer’s Disease ChartThis thickly laminated anatomical chart is printed on premium glossy (200 g) UV resistant paper and comes with 2 sided lamination (125 micron, 5.0 Mil) and metal eyelets to make the chart easy to display. It comes in a convenient poster size 50 x 67 cm (20x26’’) and can be written on and wiped off with non permenant markers. The 125 micron lamination ensures the chart does not curl up at the edges and the UV treament ensures the chart does not get a faded yellow color over time.Measurements:50 x 67 cm Weight: 0,15 kgProduct photo may not exactly match the product offered for sale. Please refer to the product description. | |
 |
Alzheimer's Disease: A Wilderness Exposed (NCME Video S103) Also With: Network For Continuing Medical Education (Primary Contributor), Kenneth L. David (Primary Contributor), Allen D. Roses (Primary Contributor), Dennis J. Selkoe (Primary Contributor), Rudolph E. Tanzi (Primary Contributor) |
 |
Natrol Extra Strength ENADA NADH, 5 mg, MicroTablets - 30 ea by Natrol The Energizing CoEnzyme. Natrol® Enada®'s NADH is a patented dietary ingredient designed for those whose active lifestyles demand the very best. As a coenzyme, NADH plays a key role in the energy production of our cells and neurotransmitter processes.* Natrol offers Enada's NADH - the only stable form of NADH in the marketplace today. This exclusive patented supplement assures maximum bioavailability. *The FDA has not evaluated this statement. This product is not intended to diagnose, treat, cure or prevent disease. If you have or suspect a medical condition, consult your healthcare professional prior to use. NADH (Vegetable source) (reduced 5 nicotinamide... |
 |
A Guide to the Spiritual Dimension of Care for People With Alzheimer s Disease and Related Dementia: More Than Body, Brain, and Breath by Eileen Shamy (Author) In this sensitive and informative book, Eileen Shamy, a pioneer of ministry to people with Alzheimer's disease, discusses how pastoral work can help to develop holistic care for those suffering from dementia and related conditions - care which involves understanding of their spiritual as well as physical needs. From her years of experience as a clergywoman working with older people in care settings, the author provides guidelines for pastoral visits to people with dementia, showing how to empathise with, understand and support individuals during a visit. She discusses what constitutes spiritual well-being in individuals and suggests ways in which this can be nurtured. Emphasising the importance of retaining dignity and freedom of choice for people with dementia, she also presents... |
 |
The Inflammation Pathway from Cholesterol to Aging - Medications and Plants that prevent and treat Aging, Cardiovascular Disease, Osteoporosis, Arthritis, Type-2 Diabetes, Dementia and Alzheimers disease by Sota Omoigui MD (Author) The Inflammation Pathway has been identified after extensive research of the medical literature, as the key trigger for Aging and many disorders associated with Aging including Heart Disease, Stroke, Skin Wrinkles, Type 2 Diabetes, Dementia, Alzheimers Disease, Osteoporosis, Arthritis and certain types of Cancers. Statin drugs act on a small branch of this pathway but yet have led to a significant decrease in mortality from Heart Disease, Stroke, Type 2 Diabetes and Dementia. Statins reduce the incidence of Arthritis and certain types of Cancers and can increase bone density and treat osteoporosis by acting on this same pathway. Dr Sota Omoigui in a major breakthrough has identified the exact way that statins and bisphosphonate medications block a minor branch of this inflammatory... |
 |
Mayo Clinic on Alzheimers Disease by M.D., Ph.D. Ronald Petersen (Editor) |
|
Alzheimer's s Disease: An Overview.: An article from: Southern Medical Journal by Ronald C. Hamdy (Author) This digital document is an article from Southern Medical Journal, published by Southern Medical Association on July 1, 2001. The length of the article is 1102 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Alzheimer's s Disease: An Overview. Author: Ronald C. Hamdy Publication: Southern Medical Journal (Refereed) Date: July 1, 2001 Publisher: Southern Medical Association Volume: 94 Issue: 7 Page: 661 Distributed by Thomson... |
| © 2009 BrightSurf.com |